We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Panel Votes to Ban OTC Inhalers
FDA Advisory Panel Votes to Ban OTC Inhalers
January 27, 2006
Nonprescription asthma inhalers should be removed from the market because they contain chlorofluorocarbons (CFCs) that harm the ozone layer, an FDA advisory panel has recommended.